Targeting the TGF-β Signaling Axis in Metastatic Colorectal Cancer: Where Do We Stand?

Int J Mol Sci. 2023 Dec 4;24(23):17101. doi: 10.3390/ijms242317101.

Authors

Kostas A Papavassiliou¹, Donatella Delle Cave², Athanasios G Papavassiliou³

Affiliations

¹ First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
² Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso', CNR, 80131 Naples, Italy.
³ Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Abstract

Colorectal cancer (CRC) represents the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide [...].

Publication types

Editorial

MeSH terms

Colonic Neoplasms*
Colorectal Neoplasms* / pathology
Humans
Rectal Neoplasms*
Signal Transduction
Transforming Growth Factor beta

Substances

Transforming Growth Factor beta